Patents by Inventor Kang-Hyun Leem

Kang-Hyun Leem has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • Patent number: 8491942
    Abstract: A use an extract of Coptidis Rhizoma or a combined extract of Coptidis Rhizoma and Pharbitidis Semen as an active ingredient for preventing and/or treating periodontal disease is provided. The extract of Coptidis Rhizoma or a combined extract of Coptidis Rhizoma and Pharbitidis Semen has activities to stimulate anti-inflammation, osteoblast differentiation and alveolar bone regeneration, and to prevent the alveolar bone destruction, thereby being effective for the prevention and/or treatment of periodontal disease.
    Type: Grant
    Filed: October 15, 2010
    Date of Patent: July 23, 2013
    Assignee: Ahn-Gook Pharmaceutical Co., Ltd.
    Inventors: Jin Auh, Chang-Kyun Han, Young-June Shin, Hyo-Jin Moon, Jong-Wook Lee, Tae-Hoo Yi, Kang-Jin Lee, Kang-Hyun Leem
  • Publication number: 20120195986
    Abstract: A use an extract of Coptidis Rhizoma or a combined extract of Coptidis Rhizoma and Pharbitidis Semen as an active ingredient for preventing and/or treating periodontal disease is provided. The extract of Coptidis Rhizoma or a combined extract of Coptidis Rhizoma and Pharbitidis Semen has activities to stimulate anti-inflammation, osteoblast differentiation and alveolar bone regeneration, and to prevent the alveolar bone destruction, thereby being effective for the prevention and/or treatment of periodontal disease.
    Type: Application
    Filed: October 15, 2010
    Publication date: August 2, 2012
    Inventors: Jin Auh, Chang-Kyun Han, Young-June Shin, Hyo-Jin Moon, Jong-Wook Lee, Tae-Hoo Yi, Kang-Jin Lee, Kang-Hyun Leem
  • Publication number: 20010026813
    Abstract: Disclosed are a Scutellariae Radix extract and a pharmaceutical preparation comprising the extract as a pharmaceutically effective ingredient. With significant neuroprotective activity, but no toxicity, the Scutellariae Radix extract is suitable for use in the prophylaxis and treatment of brain diseases, such as apoplexy, Parkinson's disease and senile dementia.
    Type: Application
    Filed: February 6, 2001
    Publication date: October 4, 2001
    Inventors: Ho-Cheol Kim, Duk-Kyun Ahn, Sun-Yeou Kim, Kyungho Suk, Young-Ok Kim, Kang-Hyun Leem